Mereo BioPharma Files Annual Report

Ticker: MREO · Form: ARS · Filed: Apr 9, 2026 · CIK: 0001719714

Mereo Biopharma Group PLC ARS Filing Summary
FieldDetail
CompanyMereo Biopharma Group PLC (MREO)
Form TypeARS
Filed DateApr 9, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: annual-report, sec-filing, biopharma

TL;DR

Mereo BioPharma filed its 2025 ARS on 4/9/26. Check it out.

AI Summary

Mereo BioPharma Group plc filed an Annual Report to Security Holders (ARS) on April 9, 2026, for the period ending December 31, 2025. The company, headquartered in London, United Kingdom, is involved in the pharmaceutical preparations industry.

Why It Matters

This filing provides shareholders with an update on the company's performance and financial standing for the fiscal year 2025.

Risk Assessment

Risk Level: low — This is a routine annual filing and does not indicate any immediate or specific risks.

Key Numbers

  • 760465 — ARS PDF Size (Size of the Annual Report to Security Holders PDF document.)
  • 1048943 — Text File Size (Size of the complete submission text file.)

Key Players & Entities

  • Mereo BioPharma Group plc (company) — Filer of the ARS
  • 0001719714 (company) — CIK number for Mereo BioPharma Group plc
  • 2026-04-09 (date) — Filing date of the ARS
  • 2025-12-31 (date) — Period of report for the ARS

FAQ

What is the primary purpose of an ARS filing?

An ARS filing, or Annual Report to Security Holders, is used by companies to provide shareholders with a comprehensive overview of their business and financial performance over the past fiscal year.

When was this specific ARS filing accepted by the SEC?

This ARS filing was accepted by the SEC on April 9, 2026.

What fiscal period does this ARS filing cover?

This ARS filing covers the period ending December 31, 2025.

What is the CIK number for Mereo BioPharma Group plc?

The CIK number for Mereo BioPharma Group plc is 0001719714.

What industry is Mereo BioPharma Group plc primarily involved in?

Mereo BioPharma Group plc is primarily involved in the Pharmaceutical Preparations industry (SIC code 2834).

Filing Details

This Form ARS (Form ARS) was filed with the SEC on April 9, 2026 regarding Mereo BioPharma Group plc (MREO).

View full filing on EDGAR

View Full Filing

View this ARS filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.